Global Factors Influencing the Rapid Evolution of the Patient Risk Stratification Market

The patient risk stratification market is set to experience remarkable growth as healare systems increasingly adopt advanced technologies to improve patient outcomes. With innovations like AI and machine learning becoming integral to healare, this market is poised for significant expansion driven by rising demand for efficient and real-time risk assessment tools.

Patient Risk Stratification Market Size Projected to Soar by 2030
The patient risk stratification market is forecasted to expand dramatically, reaching a value of $10.64 billion by 2030. This growth represents an impressive compound annual growth rate (CAGR) of 30.4%. Factors propelling this rise include the integration of machine learning and AI into risk assessment processes, broader adoption among healare providers and payers, the increasing use of cloud-based risk stratification solutions, growing demand for real-time clinical decision support, and the expansion of population health management programs. Key trends shaping the market include the widespread implementation of AI-powered risk prediction models, enhanced cloud platform deployment, greater alignment of risk stratification tools with clinical workflows, increased emphasis on real-time patient risk tracking, and more extensive use of data analytics in population health management.

Download a free report of the patient risk stratification market report:
https://www.thebusinessresearchcompany.com/report/patient-risk-stratification-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Organizations Dominating the Patient Risk Stratification Market
Several prominent companies currently lead the patient risk stratification field, including NextGen Healare Inc., Health Catalyst, Freenome, Strive Health, Medeanalytics Inc., Lightbeam Health Solutions, Graphnet Health Ltd., Equipo Health Inc., Epic Systems Corporation, Cerner Corporation, IBM Corporation, Allscripts Healare Solutions Inc., Medecision Inc., Cotiviti Inc., SAS Institute Inc., SCIO Health Analytics, Arcadia io, HealthEC LLC, Conifer Health Solutions LLC, Wellcentive Inc., ZeOmega Inc., LexisNexis Risk Solutions, Milliman Inc., NVision Health, RLDatix, Verisk Analytics Inc., Innovaccer Inc., eClinicalWorks, Enli Health Intelligence, Athenahealth Inc., i2i Population Health, 3M Health Information Systems, Change Healare, Cognizant Technology Solutions, McKesson Corporation, and Evolent Health Inc.

Significant Acquisition to Strengthen Market Position
In December 2023, Healare Outcomes Performance Company (HOPCo), a US-based organization focused on healare performance improvement and patient outcomes through data analytics, acquired MyACTome. This acquisition aims to enhance patient outcomes and healare delivery efficiency. MyACTome specializes in a smartphone-based platform that assesses fall risk and frailty, critical elements for effective patient risk stratification.

View the full patient risk stratification market report:
https://www.thebusinessresearchcompany.com/report/patient-risk-stratification-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Positive Market Trends Enhancing Patient Risk Stratification Growth
Innovations in wireless medical devices are playing a crucial role in advancing patient risk stratification. Companies are developing compact, wireless handheld ultrasound devices to improve point-of-care diagnostics and patient mobility. These devices transmit ultrasound images wirelessly to smartphones, tablets, or computers in real-time, facilitating faster clinical decisions and remote diagnostics. For example, in August 2023, GE Healare Technologies Inc. launched Vscan Air SL, a handheld wireless ultrasound imaging system featuring a dual-headed probe designed for cardiac and vascular assessments. This device supports quick diagnosis and treatment at the bedside, with high-resolution imaging powered by SignalMax and XDclear technologies, along with mobile image viewing and workflow optimization via the Vscan Air app.

Patient Risk Stratification Market Broken Down by Segments
This report segments the patient risk stratification market into several categories:
1) By Type: Predictive Risk Stratification Model, Retrospective Risk Stratification Model, Prospective Risk Stratification Model, Concurrent Risk Stratification Model
2) By Component: Software, Services
3) By Delivery Model: On-Premise, Cloud-Based
4) By Application: Risk Adjustment, Clinical Workflow, Revenue Cycle Management, Other Applications
5) By End User: Healare Providers, Healare Payers, Other End Users

Further subcategories include:
- Predictive Risk Stratification Model: Machine Learning-Based Predictive Models, Statistical Predictive Models, AI-Powered Predictive Models
- Retrospective Risk Stratification Model: Historical Data-Based Risk Models, Data Mining Retrospective Models
- Prospective Risk Stratification Model: Longitudinal Cohort-Based Models, Real-Time Risk Assessment Models
- Concurrent Risk Stratification Model: In-Hospital Risk Assessment Models, Real-Time Clinical Decision Support Models

This detailed segmentation highlights the diversity of approaches and technologies shaping the patient risk stratification market and underscores the increasing sophistication of tools available for improving healare outcomes.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.